Xinxiang Tuoxin Pharmaceutical Co.,Ltd. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was CNY 502.48 million compared to CNY 527.94 million a year ago. Revenue was CNY 502.48 million compared to CNY 527.94 million a year ago. Net income was CNY 65.71 million compared to CNY 112.8 million a year ago. Basic earnings per share from continuing operations was CNY 0.66 compared to CNY 1.19 a year ago. Diluted earnings per share from continuing operations was CNY 0.66 compared to CNY 1.19 a year ago.